KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Castle Biosciences (CSTL) over the last 3 years, with Q3 2025 value amounting to $48000.0.

  • Castle Biosciences' Non Operating Income changed N/A to $48000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $48000.0, marking a year-over-year change of. This contributed to the annual value of -$2.9 million for FY2019, which is 97830.88% down from last year.
  • As of Q3 2025, Castle Biosciences' Non Operating Income stood at $48000.0.
  • In the past 5 years, Castle Biosciences' Non Operating Income ranged from a high of $48000.0 in Q3 2025 and a low of $48000.0 during Q3 2025